e-learning
resources
London 2016
Tuesday, 06.09.2016
Smoking cessation strategies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interim report: The effectiveness of smoking cessation in tuberculosis patients and its effective factor
Mahshid Aryanpur (Tehran, Islamic Republic of Iran), Mahshid Aryanpur, Mohammad Reza Masjedi, Esmaeil Mortaz, Seyed Mohammad Reza Aryan, Zahra Hessami, Hooman Sharifi, Payam Tabarsi, Mostafa Hosseini
Source:
International Congress 2016 – Smoking cessation strategies
Session:
Smoking cessation strategies
Session type:
Thematic Poster
Number:
4307
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mahshid Aryanpur (Tehran, Islamic Republic of Iran), Mahshid Aryanpur, Mohammad Reza Masjedi, Esmaeil Mortaz, Seyed Mohammad Reza Aryan, Zahra Hessami, Hooman Sharifi, Payam Tabarsi, Mostafa Hosseini. Interim report: The effectiveness of smoking cessation in tuberculosis patients and its effective factor. Eur Respir J 2016; 48: Suppl. 60, 4307
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Impact of tobacco smoking on anti-tuberculosis treatment outcomes
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
The relationship between smoking habit and tuberculosis in patients under anti-TNF-alpha treatment
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Cigarette smoking in patients newly-diagnosed with pulmonary tuberculosis
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Impact of drug injection using on TB-AIDS treatment outcomes
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Tobacco and tuberculosis disease
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
Knowledge and attitude about tuberculosis disease in a health workers population
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Rapid monitoring of tuberculosis treatment response: A multi-centre study
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016
Joint WHO/ERS initiative on e-/m-Health for TB and tobacco control
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Impact of social support programme on MDR-TB patients' treatment outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified?
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Smoking in tuberculosis – Don’t we have the knowledge?
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
Latent TB infection: Patient choices and completion of treatment
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
The particularities of new cases of tuberculosis at homeless people
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Predictors of defaulting from treatment among patients with tuberculosis
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
The feature of BCG complications in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Assessing gender differences among tuberculosis suspects and patients in Guinea-Bissau
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept